Author:
Gra O. A.,Moskalenko M. V.,Filimonova N. A.,Baranova I. A.,Glotov A. S.,Surzhikov S. A.,Koroleva O. V.,Goldenkova-Pavlova I. V.,Nasedkina T. V.
Subject
Structural Biology,Biophysics
Reference28 articles.
1. van Staa T.P. 2006. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif. Tissue Int. 79, 129–137.
2. Kanis J.A., Stevenson M., McCloskey E.V., Davis S., Lloyd-Jones M. 2007. Glucocorticoid-induced osteoporosis: A systematic review and cost-utility analysis. Health Technol. Assess. 11, 1–231.
3. Zikan V. 2007. Glucocorticoids and osteoporosis. Vnitr. Lek. 53, 831–840.
4. De Nijs R.N. 2008. Glucocorticoid-induced osteoporosis: A review on pathophysiology and treatment options. Minerva Med. 99, 23–43.
5. Chuchalin A.G., Baranova I.A., Moskalenko M.V., Putilin A.M., Aseev M.V., Ivashchenko T.E., Demin N.V., Gorab D.N. 2006. Analysis of genetic predisposition to glucocorticoid-induced osteoporosis in patients with severe bronchial asthma. Vest. Ross. Gos. Med. Univ. 4, 39–43.